Kenvue Inc. KVUE is slated to report second-quarter 2026 results on Aug. 6, before market open. The company is likely to report top and bottom-line increase when it posts the quarterly results.For revenues, the consensus mark is pegged at $4 billion, implying a rise of 3.9% from the year-ago quarte…
Shares of Kenvue (KVUE) rose about 2% on Friday after the company announced that the U.S. Food and Drug Administration has approved Tylenol with Naproxen, a new over-the-counter pain reliever.The product pairs 650 mg of acetaminophen with 220 mg of naproxen sodium in a single dose. It begins workin…
Kenvue Inc. (KVUE) shares fell about 2% on Monday after a federal appeals court ruled that the company must face lawsuits claiming Tylenol use during pregnancy can raise the risk of autism and ADHD in children.Court RulingA three-judge panel of the 2nd U.S. Circuit Court of Appeals overturned parts…
